Skip to Content
Merck
  • Genotoxicity of 2-nitro-7-methoxy-naphtho[2,1-b]furan (R7000): a case study with some considerations on nitrofurantoin and nifuroxazide.

Genotoxicity of 2-nitro-7-methoxy-naphtho[2,1-b]furan (R7000): a case study with some considerations on nitrofurantoin and nifuroxazide.

Research in microbiology (2002-10-31)
Maurice Hofnung, Philippe Quillardet, Valérie Michel, Eliette Touati
ABSTRACT

Two nitrofurans present broad-spectrum antimicrobial properties and some of them are used in human and veterinary medicine. Most of these molecules are mutagens and some of them were reported as carcinogens. Due to its extreme mutagenic potency in bacteria, the nitronaphtho derivative 2-nitro-7-methoxy-naphtho[2,1-b]furan (R7000) was used as a tool to analyze the mechanism of the genotoxic action of this family of chemicals. In the present paper, we review essential data on the genotoxicity of R7000 and briefly discuss the case of nitrofurantoin and nifuroxazide, two nitrofurans, still in use as urinary and gastrointestinal disinfectants.

MATERIALS
Product Number
Brand
Product Description

Supelco
Nitrofurantoin, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Nitrofurantoin, VETRANAL®, analytical standard
Supelco
Nifuroxazide, VETRANAL®, analytical standard
Sigma-Aldrich
Nitrofurantoin, 98.0-102.0% (EP, UV)
Nifuroxazide, European Pharmacopoeia (EP) Reference Standard
USP
Nitrofurantoin, United States Pharmacopeia (USP) Reference Standard
2-Nitro-7-methoxynaphtho[2,1-b]furan, BCR®, certified reference material